These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Etanercept (Enbrel) for the treatment of moderate to severe plaque type psoriasis]. Piérard-Franchimont C; Piérard GE Rev Med Liege; 2006 Mar; 61(3):201-5. PubMed ID: 16681009 [TBL] [Abstract][Full Text] [Related]
4. Pilot study of recombinant human soluble tumor necrosis factor (TNF) receptor (p75) fusion protein (TNFR:Fc; Enbrel) in patients with refractory multiple myeloma: increase in plasma TNF alpha levels during treatment. Tsimberidou AM; Waddelow T; Kantarjian HM; Albitar M; Giles FJ Leuk Res; 2003 May; 27(5):375-80. PubMed ID: 12620287 [TBL] [Abstract][Full Text] [Related]
6. Etanercept in psoriasis treatment. Pietrzak A; Chodorowska G; Urban J; Roliński J; Pietrzak B Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):222-6. PubMed ID: 15314989 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of etanercept for the treatment of psoriasis: an overview of the Italian clinical experience from the real-life setting and independent studies. Vena GA; Cassano N; Piaserico S; Conti A; Girolomoni G Immunopharmacol Immunotoxicol; 2012 Dec; 34(6):901-6. PubMed ID: 22686544 [TBL] [Abstract][Full Text] [Related]
8. [Experience with an anti-TNFalpha in rheumatology]. Goupille P Ann Dermatol Venereol; 2005; 132(8-9 Pt 2):4S10-4S12. PubMed ID: 16335347 [No Abstract] [Full Text] [Related]
9. Recombinant human tumor necrosis factor receptor (p75) Fc fusion protein (TNFR:Fc) in rheumatoid arthritis. Murray KM; Dahl SL Ann Pharmacother; 1997 Nov; 31(11):1335-8. PubMed ID: 9391689 [TBL] [Abstract][Full Text] [Related]
11. New biologic therapies for psoriatic disease. Bohjanen KA; Prawer SE Minn Med; 2004 Mar; 87(3):34-6. PubMed ID: 15080292 [TBL] [Abstract][Full Text] [Related]
12. [Etanercept]. Descamps V Ann Dermatol Venereol; 2011 Dec; 138(12):845-7. PubMed ID: 22137625 [No Abstract] [Full Text] [Related]
13. A pilot study of the recombinant soluble human tumour necrosis factor receptor (p75)-Fc fusion protein in patients with myelodysplastic syndrome. Maciejewski JP; Risitano AM; Sloand EM; Wisch L; Geller N; Barrett JA; Young NS Br J Haematol; 2002 Apr; 117(1):119-26. PubMed ID: 11918541 [TBL] [Abstract][Full Text] [Related]
14. Anti-TNF agents in Crohn's disease. Van Assche G; Rutgeerts P Expert Opin Investig Drugs; 2000 Jan; 9(1):103-11. PubMed ID: 11060664 [TBL] [Abstract][Full Text] [Related]
15. Etanercept for psoriasis: two case reports. Fidalgo A; Baptista J; Rocha Páris F; Caldas Lopes L; Ferreira A Int J Clin Pharmacol Res; 2005; 25(4):159-63. PubMed ID: 16402631 [TBL] [Abstract][Full Text] [Related]
17. [Etanercept: enbrel]. Sparsa A Ann Dermatol Venereol; 2007 Dec; 134(12):972-7. PubMed ID: 18166920 [No Abstract] [Full Text] [Related]
18. A patient with neuro-Behçet's disease is successfully treated with etanercept: further evidence for the value of TNFalpha blockade. Alty JE; Monaghan TM; Bamford JM Clin Neurol Neurosurg; 2007 Apr; 109(3):279-81. PubMed ID: 17174468 [TBL] [Abstract][Full Text] [Related]